Study of Safety and Biomarker Efficacy of TS23 in Healthy Volunteer "TS23Phase1a"

Active, not recruiting

Phase 1 Results N/A

Summary of Purpose

This study is designed to determine the safety, pharmacokinetics and pharmacodynamics of a single intravenous dose of TS23 in healthy adults.

Read More →

Trial Milestones

The following dates are available for this trial. Trial information last updated on 20 December 2016.

1 Jul 2015 11 Nov 2016 1 Jun 2016 1 Jun 2017 1 Dec 2016 Unavailable
Start Date First Received 1st Completion Completion Verification Results

Trial Basics

Interventions

Conditions See All

Sponsors

Trial Design

Not available

Contacts

Not available